Healthy Fetal Growth

3
Healthy Fetal Growth


Aris T. Papageorghiou


Nuffield Department of Women’s and Reproductive Health, University of Oxford, John Radcliffe Hospital, Oxford, UK


In healthy pregnancy, fetal growth follows distinct patterns. Initially, fetal weight increases mainly due to skeletal and muscle growth and is related to placental glucose and amino acid transport. After 20 weeks of gestation there is deposition of fetal adipose tissue, which occurs alongside increases in fatty acid transport; later, fetal growth and adipose tissue deposition coincide with increasing conversion of glucose into fat [1].


Assessment of fetal size (at one point during pregnancy) and fetal growth (a dynamic process that assesses change of size over a time interval) are key elements of pregnancy care. The aim of this assessment is to identify babies that are too small or too large, due to an abnormal growth pattern. This is because it puts them at higher risk of adverse pregnancy outcome and, in the case of poor fetal growth, increased rates of perinatal mortality.


In many epidemiological studies, small (or, to a lesser degree, large) babies are defined as being of below (or above) certain birthweight thresholds, for example babies of low birthweight (below 2500 g) or very low birthweight (1500 g) [2]. These are practical cut‐offs and useful for international comparisons, and are linked to adverse outcome; for example, newborns weighing less than 2500 g are approximately 20 times more likely to die than heavier babies and are also at higher risk of a range of poor health outcomes [3].


However, the value of such cut‐offs in monitoring and comparing perinatal health between countries or over time has been questioned. This is because they are unable to distinguish those babies that are small due to preterm birth from those that are small due to fetal growth restriction (FGR), or indeed whether the two conditions coexist. In order to discriminate between these phenotypes, the gestational age must be known. This allows the size to be defined according to gestational age: small for gestational age (SGA), average for gestational age (AGA) or large for gestational age (LGA). These are usually defined as below the 10th centile, between the 10th and 90th centiles, and above the 90th centile, respectively.


Thus, in order to differentiate the normally growing fetus from the abnormal, three things must be known: (i) accurate gestational age; (ii) measurement of the fetus; and (iii) whether the measurements of size (or growth) are within the normal range compared to a standard or reference.


Estimation of gestational age


Accurate estimation of gestational age is not only important in the assessment of fetal size and growth, but also guides decisions regarding other obstetric interventions, such as prenatal testing, whether administration of prophylactic corticosteroids for fetal lung maturity and transfer to another healthcare setting is appropriate in cases of preterm labour, or when labour induction in prolonged pregnancy should occur [4]. It is also important in interpretation of results of first‐trimester screening for chromosomal abnormalities using a combination of nuchal translucency, pregnancy‐associated plasma protein‐A and free β‐human chorionic gonadotrophin (hCG) [5].


The typical length of gestation after conception is 266 days or 38 weeks (i.e. ‘conceptual age’). However, gestational age is traditionally estimated from the last menstrual period (LMP), adding 2 weeks to ‘postmenstrual age’, giving 280 days or 40 weeks. This assumes that ovulation and conception occur 14 days after LMP. This is not always the case: irregular menses, unknown or uncertain dates, oral contraceptive use or recent pregnancy or breastfeeding may all influence the accuracy of this method, and this inaccuracy is significant in a large proportion of women [6,7]. Bleeding during the first trimester can also add to difficulty in confirming gestational age clinically based on the period of amenorrhoea.


Because of this, guidelines in most developed countries support the estimation of gestational age by first‐trimester ultrasound using crown–rump length (CRL). Although this is more accurate at estimating gestational age at population level, it is important to recognize that this method too has limitations when interpreting individual results. For instance, there is an underlying assumption that all fetuses of the same size are of the same gestation, ignoring physiological differences and biological variability in size. In addition, aberrations in normal growth at very early stages of pregnancy exist and are associated with adverse outcome.


It is generally the case that assessment of gestational age in late pregnancy is less accurate than late pregnancy dating. This is because fetal ultrasound measurements are associated with a larger absolute error with advancing gestation, and because fetal growth disturbances become more prevalent, meaning that an abnormally small fetus could be misjudged to have lower gestational age (while a macrosomic fetus may be ascribed a more advanced gestational age). This limitation is of particular relevance in women who attend for their first antenatal care visit late in pregnancy and where no other reliable estimation of gestational age is available. It is known that unreliable reporting of LMP and late antenatal care are both associated with adverse pregnancy outcome; because of this, a clinically cautious approach is important when gestational age is assigned late, and particularly in the third trimester. Thus, the potential for error should be taken into account in order to ensure safe obstetric practice: for example, in preterm labour where late estimation of gestational age suggests a value above 34 weeks, prophylactic steroids or neonatal transfer should still be carried out as the gestational age may be lower by 2 weeks; in contrast, post‐dates labour induction may be appropriate at 39 weeks after late assessment of gestational age, as this could be as late as 41 weeks [8].


Although a CRL measurement may be the most accurate measure of gestational age in most pregnancies, it has been argued that clinical judgement is required in practice to determine the best approximation of the true gestational age. First, the earliest reliable ultrasound scan should be used to ascribe an estimated due date and this should not be changed subsequently as this can lead to potential dating errors. Second, all information collected at the time of that first visit (including the reported LMP and assessment of its reliability) should be taken into account. When a reliable LMP and ultrasound estimate concur, small discrepancies with actual gestational age may still exist due to inherent CRL measurement variability. Conversely, an apparently reliable and accurate LMP with a substantial difference in estimated gestational age based on CRL should be considered as an indicator of possible growth disturbance or underlying pathology that may merit further assessment [9].


Measurement of the fetus


The most common methods for estimating fetal size at any one time are by measuring fetal biometry using ultrasound; or clinically, but also less accurately, by measurement of the maternal fundal height. It has been shown that universal third‐trimester ultrasound (compared with selective ultrasound, which is only carried out based on risk factors or abnormal symphysis fundal height) is associated with greater diagnostic effectiveness as a screening test for SGA: those fetuses with reduced growth velocity were at increased risk of neonatal morbidity [10]. Nevertheless, meta‐analysis of randomized trials has failed to demonstrate benefit of routine late pregnancy ultrasound in low‐risk or unselected populations, in terms of perinatal mortality, preterm birth less than 37 weeks, caesarean section rates, and induction of labour rates [11]. It is possible that these two seemingly contradictory findings are the result of previous randomized trials lacking the use of an effective intervention after screening, or other flaws such as lack of statistical power [10].


Ultrasound


Estimation of the fetal head circumference (HC), abdominal circumference (AC), and femur length (FL) is undertaken using standard ultrasonographic planes (Fig. 3.1). Based on these parameters it is possible to calculate an estimated fetal weight (EFW). Although there are some advantages in using this estimation (for example, it is helpful in counselling parents and enabling paediatricians to make management decisions), there are disadvantages of using only a single summary measure of size. This is because individual measurement errors are compounded, resulting in 95% confidence intervals for random error in the region of 14% of birthweight. Importantly, this error is highest in exactly those pregnancies where accurate estimation is more important, namely babies with low and high birthweight [12]. Additional ultrasound measurements, including assessment of amniotic fluid and Doppler studies of uteroplacental and fetal blood flow, may aid in the clinical management of fetuses with (or at risk of) abnormal growth.

Image described by caption.

Fig. 3.1 (a) Correct ultrasound image for the measurement of the fetal head: the image is well magnified and the head is horizontal, oval in shape and symmetrical. The landmarks are (1) centrally positioned, continuous midline echo (falx cerebri); (2) midline echo broken anteriorly at one‐third of its length by the cavum septum pellucidum; (3) thalami located symmetrically on each side of the midline. (b) Correct ultrasound image for the measurement of the fetal abdomen: the image is well magnified and the cross‐section is circular. The landmarks are (1) a short segment of umbilical vein in the anterior third of the abdomen; (2) the stomach bubble is visible; (3) the spine is seen. Note that the bladder and kidneys should not be visible in this axial cross‐section. (c) Correct ultrasound image of femur length: (1) the ossified diaphysis of the femur; in the third trimester the greater trochanter (2) and distal ossification centre (3) can be seen and this allows better orientation of the imaging plane.


Fundal height


Depending on the availability of ultrasound, the setting and risk level of pregnancies, serial measurement of symphysis–fundal height (SFH) is often recommended as a simple, inexpensive, first‐level screening tool. If this is abnormal, referral for ultrasound is then carried out. Observational cohort studies show that the use of SFH measurement is associated with very wide ranges of detection of SGA babies, from as low as 17% to as high as 93%. The marked heterogeneity in these studies is thought to be due to the variety of methodologies applied, including the use of different fundal height charts, varying thresholds for defining SGA, and a suggestion of publication bias [13]. The single randomized trial in the literature, involving 1639 women, showed no reduction in the incidence of SGA between those screened and not screened with SFH measurement, and no difference in the number of perinatal deaths [14]. Although the conclusion is that there is insufficient evidence to determine whether SFH measurement is effective, it has been argued that ‘there is no suggestion that it should not be used as a screening tool’, on the basis that the method is not resource intensive [15]. This view is upheld by a number of national guidelines [16,17].

Sep 7, 2020 | Posted by in GYNECOLOGY | Comments Off on Healthy Fetal Growth

Full access? Get Clinical Tree

Get Clinical Tree app for offline access